Prices delayed by at least 15 minutes | Print
Bristol-Myers Squibb Co (BMY)
Common StockOpen
$53.39
Previous close
$53.25
Trade high
$54.475
Volume
14,348,196
Year high
$71.07
Year low
$47.58
Dividend yield
4.34%
Market capitalisation
$109.66 bn
P/E ratio
13.80
ISIN
US1101221083
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Dividends
Previous | Latest | |
---|---|---|
Record date | 05/01/2024 | 05/04/2024 |
Ex-dividend date | 04/01/2024 | 04/04/2024 |
Payment date | 01/02/2024 | 01/05/2024 |
Amount | $0.6 | $0.6 |
Company profile
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.